Tenax Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.6% | -87.2% | -28.1% | -33.8% | +1,089.9% | +7.0% | -5.0% | +4.0% | -92.9% | -100.0% | – | |
| – | -99.2% | +8.9% | +7,394.3% | +138.8% | -99.9% | +30.0% | +119.4% | -52.8% | +52,184.4% | +489.0% | +1,603.4% | |
| – | -20.2% | +1,920.1% | -98.5% | +57.3% | -55.2% | +33.0% | +6,021.4% | – | – | – | – | |
| – | – | -0.6% | -302.5% | – | -24.1% | -77.7% | -695.5% | – | – | +3.8% | -243.9% | |
| – | -25.4% | -97.4% | +57.3% | +67.4% | -53.0% | -2.3% | +50.5% | -55.7% | +22.2% | -100.0% | – | |
| – | +0.0% | – | -83.1% | +96.2% | -100.0% | – | +2,150.8% | -100.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -98.9% | +10,627.8% | – | – | – | – | – | |
| – | -43.0% | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | -19.7% | -100.0% | |
| – | -99.6% | +0.0% | +77.7% | +1,686.8% | -98.9% | +10,881.3% | -8.1% | -12.1% | +58.6% | +636.0% | -61.4% | |
| – | -187.6% | – | -232.4% | – | -169.3% | – | -149.6% | – | – | +1,009.3% | -96.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.